NOVIMMUNE
NovImmmune is committed to innovation by discovering and developing therapeutic monoclonal antibodies (mAbs) to treat patients suffering from immune-related disorders.
NOVIMMUNE
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1998-01-01
Address:
Plan-les-ouates, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.lightchainbio.com
Total Employee:
101+
Status:
Active
Contact:
41 22 839 71 41
Email Addresses:
[email protected]
Total Funding:
239.06 M USD
Technology used in webpage:
SPF IPv6 Microsoft Azure DNS Sectigo SSL Sectigo Domain SSL Vimeo Network Solutions DNS Vimeo CDN Metanet
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Aprea
Aprea is a biopharmaceutical company that develops novel cancer therapeutics.
NMD Pharma
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Rosetta Capital
Rosetta Capital investment in Series B - NovImmune
Reference Capital SA
Reference Capital SA investment in Venture Round - NovImmune
BZ Bank
BZ Bank investment in Series B - NovImmune
LODH Immunology Fund
LODH Immunology Fund investment in Venture Round - NovImmune
Aravis Ventures
Aravis Ventures investment in Venture Round - NovImmune
Ingro Finanz AG
Ingro Finanz AG investment in Venture Round - NovImmune
Varuma
Varuma investment in Venture Round - NovImmune
Pictet Private Equity Investors S.A.
Pictet Private Equity Investors S.A. investment in Venture Round - NovImmune
BZ Bank
BZ Bank investment in Venture Round - NovImmune
Novartis Venture Fund
Novartis Venture Fund investment in Venture Round - NovImmune
Official Site Inspections
http://www.lightchainbio.com Semrush global rank: 5.78 M Semrush visits lastest month: 1.44 K
- Host name: saphir.metanet.ch
- IP address: 80.74.131.91
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "NovImmune"
Light Chain Bioscience
[email protected] +41 22 552 72 00. Find us. Written by Mei Liang Belhumeur on Tuesday, 26 November 2024. Posted in News. ASH-2024 FcRH5xCD28 bispecific antibodies. ASH …See details»
Who we are - lightchainbio.com
Since mid-2019 he serves as the COO and CFO of Light Chain Bioscience – NovImmune SA. Oliver joined the Pharmaceutical company Roche in the beginning of 2006 and has held …See details»
Light Chain Bioscience – NovImmune SA - Swiss Biotech
After the successful divestment of Emapalumab related activities, we now focus on our bispecific technology to build a pipeline of multispecific antibodies under the brand Light Chain …See details»
Careers - Light Chain Bioscience AG
Ready for your next adventure ? Join our team to invent new therapies and help patients. However, we are always keen to hear from talented and motivated scientist who would like to …See details»
Light Chain Bioscience – NovImmune SA - bioalps.org
Next-generation antibody drug discovery, Immunology, Bispecific antibody drugs and Clinical development. 1. Entreprise.See details»
Light Chain Bioscience - Overview, News & Similar companies
View Light Chain Bioscience (www.lightchainbio.com) location in United States , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
Light Chain Bioscience – A brand of Novimmune SA
The rebranded website is live as of today and can be reached at www.lightchainbio.com. For more information please contact us via the contact form or via email: This email address is …See details»
Light Chain Bioscience (NovImmune) - VentureRadar
Website: http://www.lightchainbio.com/ Develops antibody-based drugs for targeted treatment of inflammatory diseases, immune related disorders, and cancer in a Swiss biotech company. …See details»
NovImmune to rebrand as Light Chain Bioscience after divesting …
Light Chain Bioscience brings to life the research and development of novel multi-specific antibodies that rely on their light chain for their function. By acquiring global rights for …See details»
Light Chain Bioscience - PitchBook
Sep 2, 2022 · Operator of a biopharmaceutical company intended to discover multispecific antibody-based drugs. The company is focused on the development of drugs that are targeted …See details»
Next-generation immunotherapy with native bispecific antibodies
Light Chain Bioscience is leveraging its proprietary bispecific antibody format to advance immune therapies in oncology and beyond.See details»
Light Chain Bioscience Adopts Genedata Biologics for Next-Gen …
Apr 19, 2022 · Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Light Chain Bioscience, a brand of …See details»
Edesa Biotech and Light Chain Bioscience Sign License ... - Nasdaq
Apr 20, 2020 · Light Chain Bioscience will be eligible to receive up to $363.5 million in aggregate development, approval and commercial sales milestone payments and other consideration. …See details»
Light Chain Bioscience Launch
NovImmune SA is excited to be launching today the all new company website and branding. Following the successful divestment of EmaCo AG, a newly established company owning …See details»
Light Chain Bioscience Chooses Genedata to Digitalize Cell Line ...
Jun 26, 2023 · Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Light Chain Bioscience, a brand of …See details»
Our mission - lightchainbio.com
We strongly believe that bispecific and multispecific antibodies can only meet their full potential if they are well tolerated by the human body. Taking advantage of the unique features of human …See details»
Edesa Biotech and Light Chain Bioscience Sign License Agreement …
Apr 20, 2020 · Light Chain Bioscience is a brand of NovImmune SA, a privately held Swiss pharmaceutical development company focused on the discovery and development of …See details»
Light Chain Bioscience successfully completes Factor VIII
GENEVA, Switzerland, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Light Chain Bioscience, a company developing bispecific antibodies with a pipeline focused in immuno-oncology, …See details»
News - Light Chain Bioscience AG
Dec 12, 2023 · Light Chain Bioscience has entered into two research collaborations and worldwide licensing agreements with Discoveric bio group. Milestones achieved under …See details»
Light Chain Bioscience - Nature
Www.lightchainbio.com Next-generation immunotherapy with native bispecific antibodies Light Chain Bioscience is leveraging its proprietary bispecific antibody format to advance immune...See details»